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ABSTRACT 18 
A study on the controlled release of Folic Acid (FA) from pH-responsive gated mesoporous silica 19 
particles (MSP) is reported. The MCM-41 support was synthesized using tetraethyl orthosilicate 20 
(TEOS) as hydrolytic inorganic precursor and the surfactant hexadecyltrimethylammonium 21 
bromide (CTAB) as porogen species. Calcination of the mesostructured phase resulted in the 22 
starting solid. This solid was loaded with FA to obtain the initial support S0. Moreover, this FA-23 
loaded material was further functionalized with 3-[2-(2-24 
aminoethylamino)ethylamino]propyltrimethoxysilane (N3) in order to obtain the gated 25 
polyamine-functionalised material S1. Solids S0 and S1 were characterized using standard solid 26 
state procedures. It was found that the functionalization process and the inclusion of FA on the 27 
pores do not modify the mesoporous structure of the starting material. FA delivery studies in 28 
water with solids S0 and S1 were carried out in water at pH 2 and 7.5. S0 was not able to 29 
completely inhibit FA delivery at acidic pH yet a rapid FA release at neutral pH was observed in 30 
few minutes. In contrast, S1 was tightly capped at pH 2 and displayed a sustained delivery of FA 31 
when the pH was switched to 7.5. In the second part of the study, FA loading and 32 
functionalization of S1-like supports was optimized. In particular, solids loaded with FA in 33 
phosphate buffered saline (PBS) and capped with N3 in acetate buffer at pH 2 exhibited a delivery 34 
capacity up to 95g FA/mg solid. Finally, FA release from the selected optimized supports was 35 
studied following an in vitro digestion procedure. The results showed that amine-capped MSP 36 
were not only able to hinder the release of the vitamin in gastric fluids (pH 2), but were also 37 
capable of deliver progressively the FA in presence of a simulated intestinal juice (pH 7.5) offering 38 
a suitable mechanism to control the bioaccessibility of the vitamin.  39 
 40 
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 43 
1. Introduction  44 
 45 
Folate is a generic term by which is known a group of water-soluble compounds with B9 vitamin 46 
activity and with chemical structures similar to synthetic pteroyl monoglutamic acid (PGA), 47 
commonly known as folic acid (FA). Folates are essential to numerous bodily functions, including 48 
DNA synthesis and repair, cell division and cell growth [1]. Main folate sources include green leafy 49 
vegetables, yeast extracts, liver, kidney, and citrus fruit. Despite this wide distribution, folate 50 
deficiency is a common finding that can be caused by a variety of factors such as malabsorption of 51 
folate from the diet, an increased utilization by the body or a significant loss up to 50% during 52 
cooking processes [2]. FA deficiency is such important in humans that it can cause neural tube 53 
defects in developing embryos [3], is associated with elevated plasma homocysteine (an emerging 54 
risk factor for vascular diseases), with cognitive decline and neurodegenerative diseases such as 55 
Alzheimer and also is risk factor for certain tumours (acute lymphoblastic leukaemia, breast 56 
cancer, and gastric cancer) [4,5]. 57 
 58 
To prevent the occurrence of these and other diseases, food supplementation with folates is 59 
mandatory in certain countries such as USA [6], Canada [7] or UK [8] with the objective of ensure 60 
a 400 μg intake for adults and an additional 200 μg for pregnant women [9]. To achieve this 61 
supplementation, the most employed molecule is FA, due to its high stability and bioavailability 62 
[10].  63 
 64 
Although there are irrefutable evidences about the benefits of FA supplementation to prevent 65 
some diseases, recent studies suggest that the margin of the benefit is very narrow, and despite 66 
the necessity of the supplementation, a massive exposition to high bioavailable FA could be a 67 
double-edged sword [8]. In particular it has been reported that biotransformation processes of FA 68 
are saturated at doses of 266-400 g of FA and up to this amount unmetabolized FA is found in 69 
plasma, which could be correlated with the increase of cancer risk, insulin resistance, 70 
preneoplastic and neoplasctic lesions [11]. In this context, the design of systems to dosage FA 71 
along the digestion and therefore modulating its bioaccessibility and bioavailability is a challenge 72 
for current nutritional science.  73 
 74 
The bioaccessibility of a nutrient is defined as the amount of the nutrient that is released from a 75 
food matrix during digestion and made accessible for absorption into the intestinal mucosa [12]. 76 
One possibility to modulate bioaccessibity of a molecule consists of its encapsulation and later 77 
controlled release under suitable stimuli. Organic-based ensembles using lipids or carbohydrates 78 
have been reported as classical encapsulation systems [13]. However, they have some important 79 
drawbacks, such as the difficulty for a scale production [14, 15], low stability of the structure 80 
during food processing and storage, difficulty of controlling the release rate and also a poor 81 
capability to protect the encapsulated substance through the harsh stomach conditions [16]. As 82 
an alternative, systems based in polyalcohols, polyamides, celluloses [17] or in mesoporous 83 
inorganic materials [18], have been recently developed as suitable systems for controlled delivery 84 
applications. In particular, mesoporous silica particles (MSP) exhibit unique features as supports 85 
for controlled release, such as high stability [19], biocompatibility [20], no apparent toxicity [21], 86 
large load capacity [22], and the possibility to include gate-like scaffoldings on the external 87 
surface. This last characteristic allows the design of carriers for on-command delivery in the 88 
presence of target physical (such as light, temperature) [23, 24], chemical (pH-changes, redox 89 
potencial) [25-29] and biomolecules (enzymes, antibodies, DNA) [30-33] stimuli. Of those, several 90 
gated MSP have proved to show “zero” delivery yet are able to release the cargo under digestive 91 
stimuli [34, 35]. In particular, gated ensembles based in amines have been reported to be suitable 92 
systems for cargo delivery upon pH changes.  93 
 94 
The purpose of this study is, on one hand, to evaluate the use of MSP capped with amines as 95 
suitable pH-responsive systems capable to modulate FA delivery and bioaccesibility in in vitro 96 
digestion assays and on the other hand, to optimize the loading process in these materials to 97 
achieve the release of the recommended dietary intake of folic acid using the minimum amount 98 
of inorganic matrix. As far as we know, this is the first time that an optimization of folic acid 99 
loading in MSP and a study of in vitro delivery from MSP of this molecule of nutritional interest is 100 
reported.  101 
 102 
 103 
2. Materials and methods  104 
 105 
2.1 Chemicals 106 
Tetraethylorthosilicate (TEOS), n-cetyltrimethylammonium bromide (CTABr), sodium hydroxide 107 
(NaOH), triethanolamine (TEAH3),  the  organosiloxane derivative 3-[2-(2-108 
aminoethylamino)ethylamino]propyl (N3), NaH2PO4, Na2HPO4 and Tetrabutylammonium 109 
hydrogen 3ulphate (TBAHS) and all chemicals for the digestive fluids were provided by Sigma-110 
Aldrich (Poole, Dorset, UK). Folic acid was purchased from Schircks Laboratories (Jona, 111 
Switzerland). Acetonitrile HPLC grade was provided by Scharlau (Barcelona, Spain). 112 
 113 
2.2 FA molecular structural mechanics simulations   114 
Theoretical calculations of the structure of FA were carried out by using HyperChem 8.0.6 Molecular 115 
Modeling System (Hypercube Inc., Gainesville, FL, USA). The calculation of geometry was performed using 116 
molecular mechanics MM+ in a first step and AMBER in a second step. Full geometry optimizations were 117 
carried out in vacuum employing the Polak-Ribiere conjugate gradient method until an RMS gradient of 118 
0.1 kcal/mol was reached. The final 3D structure was refined by optimization of the geometry using 119 
molecular dynamics methods at a simulation temperature of 300 K. QSAR properties of the vitamin were 120 
determined. 121 
 122 
2.3 Synthesis of MCM-41 123 
The mesoporous MCM-41 support was first synthesized using the so-called “atrane route” in 124 
which 4.68g of CTAB were added at 118°C to a solution of TEAH3 (25.79 g) containing 0.045 mol of 125 
a silatrane derivative (11 mL of TEOS). Next, 80 mL of water was slowly added with vigorous 126 
stirring at 70 °C. After few minutes, a white suspension was formed. This mixture was aged at 127 
room temperature overnight. The resulting powder was collected by filtration and washed with 128 
water and ethanol. Finally, the solid was dried at 70 °C. To prepare the final mesoporous material, 129 
the as-synthesized solid was calcined at 550 °C using an oxidant atmosphere for 5 h in order to 130 
remove the template phase.  131 
 132 
2.4 Synthesis of S0 and S1 133 
100 mg of MCM-41 and 0.035 g (0.08 mmol) of FA were suspended in 7 mL of phosphate buffered 134 
saline (PBS) inside an amber round-bottom flask in an inert atmosphere. The mixture was stirred 135 
for 24h at room temperature to achieve the maximum loading in the pores of the MCM-41 136 
scaffolding. The loaded solid (S0) was isolated by vacuum filtration, washed with 300 mL of water 137 
adjusted to pH 2, and dried at room temperature for 24h. This loading process was optimized in 138 
further assays (vide infra in 2.5).  139 
 140 
To obtain S1, 100 mg of S0 were suspended in 4 mL of acetonitrile and an excess of N3 (0.43 mL, 141 
0.015 mmol) was added. The final mixture was stirred for 5.5 h at room temperature. The loaded 142 
and functionalized solid (S1) was isolated by vacuum filtration, washed with 300 mL of water 143 
adjusted to pH 2, and dried at room temperature for 24h.  144 
 145 
2.5 Folic acid release studies 146 
To determine the effect of pH in FA release from the non-gated (S0) and amine-gated (S1) 147 
mesoporous silica particles, 10 mg of the corresponding solids (S0 or S1) were placed in 25 mL of 148 
water at pH 2 and pH 7.5. At a certain times aliquot were separated, the suspension filtered and 149 
the solution analysed by HPLC.  150 
 151 
2.6 Folic acid loading optimization 152 
With the aim of optimize the amount of FA loaded inside the MSP, two different loading methods 153 
were tested: immersion (A) and impregnation (B). Table 1 summarizes the 8 loading conditions 154 
assayed. Solids were synthetized by triplicate.  155 
 156 
For the immersion method (A), 100 mg of MCM-41 were immersed into a PBS solution containing 157 
4 different amounts of FA, stirred for 24 h, filtered and washed. Then, loaded solids were 158 
functionalized with 0.43 mL of N3 in acetonitrile following the procedure described in the 159 
synthesis of S1. Using this method, 4 different loaded and functionalized solids were obtained 160 
(A1-4).  161 
For the impregnation method (B), FA dissolved in PBS (10mg/mL) was added to 100 mg of MCM-162 
41 employing 4 different FA amounts and cycles of addition (see Table 1). After each addition 163 
cycle solids were dried at 30ºC to eliminate water content. Then, each of the loaded solids (B1-4) 164 
were functionalized with 0.43 mL of N3 using different media; i.e. water at pH 2 (solids BW#), 165 
acetate buffer at pH 2 (BB# solids) or acetonitrile (BA# solids). The loaded and functionalized 166 
solids were isolated by vacuum filtration, washed with 300 mL of water adjusted to pH 2 with HCl, 167 
and dried at room temperature for 24h. Finally, 12 solids were obtained: 4 functionalized in water 168 
at pH 2 with HCl (BW1-4), 4 functionalized in acetate buffer at pH2 (BB1-4) and 4 functionalized in 169 
acetonitrile (BA1-4).  170 
 171 
Table 1. Conditions employed in loading optimization assays: immersion method (A) and 172 




Solid MCM (mg) Folic (mg) PBS 
(mL) 
Cfolic (mg/mL) Cycles (amount of 
solution per cycle) 
Immersion 
 
A1 100 35 7 5  
A2 100 35 3.5 10  
A3 100 70 7 10  
A4 100 70 3.5 20  
Impregnation B1 100 10 1 10 1 (1 mL) 
B2 100 10 1 10 2 (0.5 mL) 
B3 100 15 1.5 10 3 (0.5 mL) 
B4 100 20 2 10 4 (0.5 mL) 
 175 
 176 
2.7 Loading efficiency evaluation 177 
Loading efficiency of each of the 16 obtained solids was determined by quantification FA 178 
delivered in PBS after 5h by HPLC. The “relative loading efficiency” was calculated according to 179 
the following equation: 180 
 181 
Relative loading efficiency (%) = FAD/FAL x 100 182 
 183 
where FAD are the mg of folic delivered per 1mg of loaded solid and FAL are the mg of folic acid 184 
employed for the loading of 1 mg of MCM-41. 185 
 186 
2.8 Determination of in vitro folic acid bioaccessibility 187 
FA bioaccessibility (FA delivery from the prepared solids) was determined by simulating a human 188 
digestion in the stomach and small intestine adapting the procedure described by Versantvoort et 189 
al. [36] (Fig. 1). The large intestinal track was not taken into account since in vivo folic acid 190 
absorption occurs throughout the jejunum [1]. In a typical experiment, 10 mg of the 191 
corresponding solid were suspended in 12 mL of gastric juice and incubated for 2h at 37ºC. 192 
Finally, 12 mL of duodenal juice, 6 mL of bile, and 2 mL of bicarbonate solution (1M) were added 193 
simultaneously. After the addition, the mixture was maintained under stirring at 37ºC for 2h. All 194 
digestive juices were heated to 37ºC before being mixed. During this period aliquots were taken, 195 
filtered and analysed by HPLC.  196 
 197 
 198 
Figure 1. Schematic representation of the in vitro digestion model. 199 
 200 
2.9 Folic acid determinations 201 
FA was determined by reversed-phase gradient HPLC method according to the method described 202 
by Póo-Prieto et al. [37] with minor modifications. The HPLC instrument consisted of a Hitachi 203 
LaChrom Elite liquid chromatograph (Hitachi Ltd., Tokyo, Japan) equipped with an auto-sampler 204 
and UV detector (model L-2400). A Kromaphase 100 C18 (250 mm x 4.6 mm i.d., 5 m particle size 205 
analytical column) (Scharlab, Barcelona, Spain) was used for the separations. Mobile phase 206 
consisted of (A) 0.125 mM of NaH2PO4, 0.875 mM of Na2HPO4 and 0.4mM of TBAHS in water and 207 
(B) acetonitrile-phase A 65:35 (v/v). The flow rate employed is described in table 2. The 208 
wavelength of UV detector was set at 280 nm. Solutions for preparation of calibration standards 209 
were made at 1, 5, 10, 25, 50, 75, 100 g FA/mL in PBS. 210 
 211 
Table  2.  Elution program for HPLC analysis. 212 
Time (min) Flow (mL/min) Mobile phase A (%) Mobile phase B (%) 
0 1.0 90 10 
5 1.0 90 10 
15 1.0 64 36 
30 1.0 40 60 
35 1.0 90 10 
40 1.0 90 10 
 213 
A: NaH2PO4 (0.125 mM), Na2HPO4 (0.875 mM ) and TBAHS (0.4mM) in water. 214 
B: Acetonitrile-Phase A 65:35 (v/v) 215 
 216 
2.10  Solids characterization 217 
X-ray diffraction (XRD), transmission electron microscopy (TEM), N2 adsorption-desorption 218 
isothermes and thermogravimetric analyses (TGA) were employed to characterize the synthesized 219 
materials. XRD were performed on a BrukerD8 Advance diffractometer using CuKα radiation. TEM 220 
images were obtained with a JEOL JEM-1010. The N2 adsorption-desorption isotherms were 221 
recorded by a Micrometrics ASAP2010 automated sorption analyser. Samples were degassed at 222 
90ºC in vacuum, overnight. The specific surface areas were calculated from the adsorption data 223 
within the low pressure range using the BET model. Pore size was determined following the BJH 224 
method. Thermogravimetric analyses were carried out on a TGA/SDTA 851e Mettler Toledo 225 
balance, using an oxidant atmosphere (air, 80 mL/min) with a heating program consisting of a 226 
heating ramp of 10 °C per minute from 393 to 1273 K and an isothermal heating step at this 227 
temperature for 30 min. 228 
 229 
 230 
2.11 Data analysis 231 
The results of the FA delivery from the different solids prepared were statistically processed using 232 
Statgraphics Centuriun XV (Manugistics Inc., Rockville, MD, USA). Statistical analysis on FA 233 
concentrations was made using an analysis of variance (One-Way ANOVA). 234 
  235 
3. Results and discussion 236 
 237 
3.1 FA molecular modelling and geometrical dimensions 238 
 239 
Molecular dynamics calculations on FA were carried out. The molecular structure of FA is shown 240 
in Figure 2. As it can be seen, FA (pteroyl monoglutamic acid) consists of a pteridin ring linked to 241 
the para-amino benzoic acid (PABA) and a molecule of glutamic acid. In the larger dimension, FA 242 
exhibits a length of 1.45 nm, whereas the calculated volume is 1.16 nm3. These calculations were 243 
used to determine the total theoretical amount of vitamin that could be encapsulated in the silica 244 
mesoporous matric (vide infra).  245 
 246 
 247 
Figure 2. 3D FA molecular structure and geometrical dimensions  248 
 249 
3.2 Design, synthesis and characterization of the gated particles 250 
For the design of the proposed pH-controlled and sustained release system described above 251 
MCM-41 mesoporous silica microparticles were selected as an inorganic support due to its high 252 
loading capacity, homogeneous porosity in the 2–3 nm range, high inertness, and ease of 253 
functionalization. This starting support was loaded with FA to obtain solid S0. Moreover, this FA-254 
loaded material was further capped with a pH-responsive ensemble (i.e. 3-[2-(2-255 
aminoethylamino)ethylamino]propyltrimethoxysilane, N3) in order to obtain the gated 256 
polyamine-functionalised material S1. In this work pH was chosen as a suitable digestive stimulus 257 
for the modulation of FA release from the inner of the MCM-41 voids. In stomach, pH is very acid 258 
(pH 1-2) to help the degradation of proteins and to provide a non-specific immunity, retarding or 259 
eliminating various pathogens. In the small intestine, the duodenum provides critical pH balancing 260 
to activate digestive enzymes. The liver secretes bile into the duodenum to neutralise (pH 7-7.5) 261 
the acidic conditions from the stomach. Also the pancreatic duct empties into the duodenum, 262 
adding bicarbonate to neutralize the acidic chyme, thus creating a neutral environment. FA is 263 
known to be mainly absorbed in the small intestine (jejunum; pH 7.5) from where it is distributed 264 
to the tissues through the bloodstream and stored in the liver.  265 
 266 
As stated above, pH has been chosen in this paper as triggering stimulus. In this particular system 267 
changes in the pH are expected to modulate FA delivery in two different ways. On the one hand, it 268 
is known that FA under neutral/basic conditions is about 1000 times more soluble than FA in an 269 
acidic environment due to protonation (acid) and deprotonation (neutral/basic) of FA in aqueous 270 
environments [38]. On the other hand, it has been reported that MSP functionalised with the 271 
polyamine derivative 3-[2-(2-aminoethylamino)ethylamino]propyl-trimethoxysilane (N3) are 272 
suitable pH-responsive controlled release systems able to allow or inhibit delivery as a function of 273 
pH changes due to the transformation of amines (open gate at neutral/basic pH) to 274 
polyammonium groups (closed gate at acidic pH). These two mechanisms of action are illustrated 275 
in Figure 3.  276 
 277 
Figure 3. Illustration of the synthetic procedure for the preparation of solids S0 and S1, and the 278 
mechanism of FA delivery at neutral or acidic conditions.   279 
 280 
The different solids prepared were characterized according to standard techniques. X-ray patterns 281 
of the solids MCM-41 as synthesized (a), calcined (b), loaded with folic acid (S0) (c) and loaded 282 
with folic acid and functionalized with amines (S1) (d) are shown in Figure 4. Curve a shows the 283 
expected four peaks of a hexagonal ordered array indexed as (100), (110), (200) and (210) Bragg 284 
reflections. A significant shift of the (100) reflection in the XRD powder of the MCM-41 calcined 285 
sample is clearly appreciated in the curve b, corresponding to a cell contraction related to 286 
condensation of silanols during the calcination step. Curves c and d show that reflections (110), 287 
(200) and (210) are lost, most likely due to a reduced contrast that can be attributed to the 288 
presence of FA in the pore voids and the anchored N3 molecule. Nevertheless, the existence in all 289 
cases of the (100) peak in the XRD patterns indicated that the process of pore loading with FA, 290 
and the additional functionalization with the polyamine, did not modify the typical porosity of the 291 
mesoporous MCM-41 scaffold. 292 
 293 
 294 
Figure 4. Powder X-ray patterns of the solids (a) MCM-41 as-synthesized, (b) MCM-41calcined, (c) 295 
the uncapped solids containing the vitamin B9 (S0) and (d) the capped mesoporous system (S1). 296 
 297 
The MCM-41 mesostructure mesostructure after loading with FA and functionalization with 298 















Figure 5. TEM image of (a) MCM-41 calcined and (b) solid S1 showing the typical porosity of the 314 
MCM-41 matrix. 315 
 316 
The N2 adsorption-desorption isotherms of the starting MCM-41 calcined material are shown in 317 
Figure 6. The curve shows a well defined and sharp adsorption step at P/P0 values between 0.1 318 
and 0.3, corresponding to a type IV isotherm, which is typical of mesoporous materials, attributed 319 
to nitrogen condensation in the mesopore inlets. With the Barrett-Joyner-Halenda (BJH) model on 320 
the adsorption curve of the isotherm, pore diameter and pore volume were calculated to be 2.52 321 
nm and 0.92 cm3g-1, respectively. The absence of a hysteresis loop in this interval and the narrow 322 
BJH pore distribution suggested the existence of uniform cylindrical mesopores. The application of 323 
the BET model resulted in a value of 1040 m2/g for the total specific surface. From the XRD, 324 
porosimetry and TEM studies, the a0 cell parameter (3.98 nm), the pore diameter (2.52 nm), and a 325 
value for the wall thickness of 1.69 nm were calculated.  326 
 327 
Considering the pore size of the MCM-41 support and the FA structure (see section 3.1), it can be 328 
stated that FA can be perfectly encapsulated in pores of 2.52 nm of diameter. Moreover, bearing 329 
in mind the volume of the FA molecule (1.16 nm3), the specific volume of the MCM-41 (0.92 330 
cm3/g) and tentatively assuming that ca. 75% of the pore volume in the mesoporous support can 331 
be occupied by FA, it can be roughly stablished that 1 mg of MCM-41 could host as a maximum 332 
436 g (0.98 mmol) of FA in its porous network. 333 
 334 
Table 3 also shows the change on the textural properties of the starting silica after the vitamin 335 
adsorption (S0) and the functionalization with the N3 molecule (S1). The incorporation of the FA 336 
leads to a decrease of ca. 37% and 46% for the BET surface area and the BJH mesopore volume, 337 
respectively. This evolution indicates that the FA molecules must be incorporated inside the 338 
mesopores. Under the pH conditions used for the drug uptake (7.5), the two carboxilate groups 339 
must be deprotonated, and consequently, the interaction with the silanol groups at the silica 340 
surface must be mediated by H+ species. Taking into account the presence of partially filled 341 
mesopores in the solid S0 together with the relatively large arm of the N3 molecule, the 342 
incorporation of these last species preferentially must occurs in the external surface at the 343 
mesopore entrances. As expected, the incorporation of the N3-gates leads to an additional 344 
decrease of both the surface area as the volume of 31 and 57%, respectively.  In a parallel way, 345 
200 nm 100 nm 
the size of the mesopores decreases after FA inclusion. A large variety of FA aggregates on the 346 
silica are possible which is consistent with the wider peak observed in the pore size distribution 347 
curve. An additional mesopore size reduction occurs after functionalization with N3 groups. 348 
Hence, solid S1 shows a wide pore size distribution with a principal peak centred at 1.82 nm and a 349 
residual signal at ca. 2.38 nm. The first peak could be associated to a majority of the mesopores 350 
well surrounded by N3 molecules and the residual peak must be attributed to a small proportion 351 




Table 3. Analytical and textural parameters from TGA and N2 adsorption-desorption isotherms. 356 
 357 
 SBET (m2g-1) Pore volume 
(cm-3g-1) 
Pore size (nm) 
MCM-41 1040 0.92 2.52 
S0 653 0.49 2.28 





Figure 6. Nitrogen adsorption-desorption isotherms (a) and pore size distribution (b) for MCM-41 362 
mesoporous material,  S0, and S1 materials.  363 
 364 
 365 
3.3 pH gate-like mechanism confirmation 366 
FA delivery from the uncapped solid S0 in acid and neutral conditions was studied. In a typical 367 
experiment 5 mg of S0 were suspended in 25 mL of two different aqueous solutions (pH 2 and pH 368 
7.5) in an attempt to reproduce the pH of gastric or intestinal fluids.  The release profile of S0 is 369 




Figure 7. Release profiles of folic acid from the pores of solid S0 in water at pH 2 (unfilled marker 374 
points) and pH 7.5 (filled marker points). Values are Means±SD, n=3. 375 
 376 
 377 
As observed in the Figure 7, the asymptote of the release curve was achieved in the first few 378 
minutes of the delivery at pH 7.5. According to TGA experiments, the maximum delivery achieved 379 
(indicated in the figure as 100%) corresponds to 32% of the FA content in the solid. This indicated 380 
that, under the experimental conditions, not all the FA loaded was able to be released. In 381 
contrast, only a 14.9±1.2% of the maximum delivery capacity was achieved at pH 2 (which 382 
corresponds to ca. 5% of the total FA content determined by TGA). Considering that the increase 383 
of FA concentration in the water phase is proportional to the delivery of the vitamin from the 384 
pores and that FA release is not inhibited by the presence of functional molecular groups on the 385 
surface of the MCM-41, the effect of solubility in FA bioacessibity (release) is confirmed. At pH 2, 386 
FA is in the form of acid with low solubility, while at pH 7.5 folic is in the form of salt, increasing its 387 
solubility, and enhancing the delivery [39] from the pore voids of S0 to the solution. However, as 388 
it can be seen in figure 7 this pH-induced “solubilisation mechanism” is insufficient to modulate a 389 
sustained release of FA, a fact that would not allow a proper absorption of FA in the jejunum. 390 
 391 
In a second study, delivery of FA from S1 was tested using similar delivery conditions; i.e. 5 mg of 392 
S1 were suspended in 25 mL of two different aqueous solutions at pH 2 and pH 7.5. As shown in 393 
Figure 8, FA delivery after 4h at pH 2 achieved values 0.22±0.03% of the maximum delivery 394 
capacity of S1 (which corresponds to ca. 0.09% of the total FA content determined by TGA). In 395 
contrast, at pH 7.5, a progressive delivery of the vitamin was observed, achieving ca. 100% of the 396 
release capacity in the performed conditions after 1h (which corresponds to 40% of FA content 397 
determined by TGA). In this case, the pH-dependent release behaviour can be explained by 398 
considering the different FA solubility as a function of the pH and the presence of the gate-like 399 
ensemble based in polyamines. To explain this latter effect, it has to be taken into account that at 400 






















fact favours Coulombic repulsions between closely located polyammonium groups, so that 402 
tethered polyamines tend to adopt a rigid-like conformation that blocks the pores and practically 403 
no release occurs. At pH 7.5, a lower proportion of polyamines are expected to be protonated, 404 
favouring hydrogen bond interactions between the different amine chains. As a consequence, 405 
pores unblock and vitamin release is produced. Moreover, in amine-based gated ensembles a 406 
second cooperative anion-dependent effect occurs. In general polyamines are well-known pH-407 
responsive molecules that can additionally complex anions via electrostatic forces and by 408 
formation of hydrogen-bonding interactions in a wide pH range. Additionally, the relative 409 
amine/ammonium ratio can control the interaction with anionic species. If electrostatic forces are 410 
taken into account (which in general are stronger than hydrogen bonding interactions) the 411 
presence of a large percentage of ammonium groups (acidic pH) will favour the interactions of the 412 
“gate” with anions in the solution resulting in an additional pore blockage that is not observed at 413 
neutral or basic pH [40]. 414 
 415 
Comparing the delivery profiles at pH 2 and 7.5 of the uncapped (S0) and capped (S1) materials it 416 
is apparent that S0 is not able to completely inhibit FA delivery at acidic pH being the delivery very 417 
fast at neutral pH. In contrast, S1 is tightly capped at pH 2 and displays a sustained delivery (in 1h) 418 
when the pH is switch to 7.5. It can be concluded that the gated support S1 might be a suitable 419 
prototype for the development of orally applicable FA delivery systems designed to block cargo 420 
delivery in the acidic conditions of the stomach (acid pH, gate closed) yet be able to display a 421 
sustained FA release at the intestine (basic pH, gate open). 422 
 423 
 424 
Figure 8. Release profiles of folic acid from the pores of solid S1 in water at pH 2 (unfilled marker 425 
points) and pH 7.5 (filled marker points). Values are Means±SD, n=3 426 






















3.3 Loading/releasing optimization process  428 
 429 
After studying the delivery of FA from the polyamine-functionalised (S1) and unfunctionalised (S0) 430 
materials, this section deals with a detailed study of FA loading optimization for the preparation 431 
of functionalised solids (S1-like supports). For this purpose, 16 solids differing in the loading 432 
(immersion and impregnation) and the functionalization media used to anchor the polyamine N3 433 
(water at pH 2, acetate buffer at pH 2 or acetonitrile) were prepared. Delivery effectiveness of 434 
each solid was evaluated by the determination of FA delivered after 5h at pH 7.5. Moreover, the 435 
loading/delivery performance of the solids was evaluated using the “relative loading efficiency” 436 
via the determination of the ratio between the amount of FA delivered (after 5h at pH 7.5) per mg 437 
of loaded solid and the mg of FA used for loading 1 mg of MCM-41 (see Experimental Section for 438 
details). 439 
 440 
The first block of bars of Figure 9 shows values of FA delivered per mg of A# solids, solids obtained 441 
by using a traditional immersion procedure. Among them, solid A1 was able to deliver 3.7±0.2 g 442 
of FA/mg of solid. By increasing the amount of FA present in the loading solution to 70mg 443 
(0.016mmol) (A3) the amount delivered increased to 21.2±0.3 g of FA/mg of solid. However, 444 
when the same amount of folic was loaded in the half of solvent, the release capacity decreased 445 
(A4) to 6.2±0.2g of FA/mg of solid. To understand this behaviour the maximum FA amount able 446 
to be solubilized in PBS was determined, finding that above of 10mg of FA/mL PBS, FA remains 447 
insolubilized, and thus, cannot participate in the loading process. 448 
 449 
The same figure shows values of FA delivered by solids loaded by impregnation and functionalized 450 
in water at pH 2 (BW#), acetate buffer at pH 2 (BB#) or acetonitrile (BA#).  As it can be seen, BW# 451 
solids exhibited the lowest loading capacity. In fact the 4 solids prepared using these conditions 452 
were white, strongly suggesting the presence of a very low amount of FA (pale yellow) in the 453 
pores. To understand the cause of this behaviour, it was found that pH reached values of 10 upon 454 
the addition of the amine N3 during the synthesis of the solid. At this pH FA is highly soluble and 455 
most likely leaked from the pore voids during the synthesis of the materials. In contrast, B solids 456 
functionalized with N3 in aqueous acetate buffer (BB# solids) or acetonitrile (BA# solids), showed 457 
a remarkable larger FA delivery in water. In this case, the poor solubility of FA in the acetate 458 
buffer or acetonitrile during the N3 functionalization avoided the FA leakage during this step of 459 
the synthesis. When both BA# and BB# solids are compared in terms of delivery, it can be stated 460 
the BB# series display larger delivery ability. In particular, BB# solids exhibited a remarkable 461 
delivery capacity (p<0.005), being solid BB4 able to release 127±5g of FA/mg of solid (see Figure 462 
9). As a conclusion, the choice of the solvent employed for the surface functionalization step is as 463 
important as the loading procedure in terms of loading efficiency. Nevertheless, the maximum 464 
loading capacity calculated in section 3.2 has not been achieved in any of the designed solids. 465 
 466 
 467 
Figure 9. Maximum FA delivery (g FA/mg solid) for different solids loaded by immersion in PBS 468 
and functionalized with N3 in acetonitrile (A# solids) or loaded by impregnation and 469 
functionalized with N3 in different solvents: water adjusted to pH 2 (BW), acetate buffer at pH 2 470 
(BB) or acetonitrile (BA). Numbers 1-4 refers to different FA loading conditions described in Table 471 
1. Values are Means±SD, n=3. 472 
 473 
From the release ability displayed by the different solids prepared and taking into account the 474 
amount of FA employed for the loading of each solid, the relative loading efficiency (RLE) was 475 
calculated. Figure 10 shows RLE values for the 16 prepared solids. As expected, solids loaded by 476 
immersion (A#) were the less efficient in terms of delivery with RLE values of around 1-3%. 477 
Moreover RLE values of ca. 2.5-5%, 40-60% and 63-75% were observed for BW#, BA# and BB# 478 
supports. In addition, for solids BA# and BB# RLE increased significantly (p<0.005) from 10 mg in 1 479 
cycle (#1 solids) to 15 mg in 3 cycles (#3 solids). However, the addition of 1 extra cycle of addition 480 
(#4 solids) did not increase RLE values indicating that, in this case, not all the FA added was loaded 481 
inside the pore voids of the mesoporous materials. According to these results, the conditions 482 
employed for preparing solid BB3 should be considered as optimal, in terms of RLE values, for the 483 
preparation of MSP loaded with folic acid and gated with N3 moieties.  484 
 485 
All these prepared solids were characterized using standard techniques. In all cases XRD patterns 486 
and TEM images (data not shown) were equivalent to those obtained for solid S1 (section 3.1), 487 
confirming that the mesoporous structure of the MCM-41 scaffold was maintained in spite of the 488 































Figure 10. Relative Loading Efficiency for different solids loaded by immersion in PBS and 493 
functionalized with N3 in acetonitrile (A# solids) or loaded by impregnation and functionalized 494 
with N3 in different solvents: water adjusted to pH 2 (BW# solids), acetate buffer at pH 2 (BB# 495 
solids) or acetonitrile (BA# solids). Numbers 1-4 refers to different FA loading conditions described 496 
in Table 1. Values are Means±SD, n=3. 497 
 498 
3.4 In vitro Folic Acid bioaccessibility and nutritional implications 499 
 500 
After the loading optimization procedure described above, this section deals with the use of solid 501 
BB3, which exhibited the maximum RLE value, for delivery studies in a more realistic media. In 502 
particular, the aim of this part was to study FA release, and therefore FA bioaccessibility, during a 503 
simulated pass of the solid through the gastrointestinal tract. To evaluate this, a variation of the 504 
dynamic in vitro digestion protocol reported by Versantvoort et al. [36] was performed. Briefly 505 
BB3 was suspended in simulated gastric juice and incubated for 2h at 37ºC and then duodenal 506 
juice, bile and bicarbonate solution were added to obtain a simulated intestinal fluid (see 507 
Experimental Section for details). Note that in this study the pass of the solid through large 508 
intestinal track was not taken into account since in vivo folic acid absorption occurs throughout 509 
the jejunum [1]. At certain times aliquots were taken, filtered and analysed by HPLC. Results of FA 510 
delivery from BB3 are shown in Figure 11. During the first two hours of simulated digestion, 511 
where BB3 solid was in contact with a simulated gastric fluid, only 10.2±1.4 g of FA/mg of solid 512 
were delivered. After the addition of the simulated intestinal fluid, FA delivered increased 513 































   
   
   
   
   
   
   
   
   
   
   
   






Figure 11. Release profile of FA from solid BB3 along the simulated gastrointestinal digestion 517 
process. Time 0-2h correspond to the simulation of stomach conditions and time from 2-4h 518 
correspond with the simulation of intestinal conditions. Values are Means±SD, n=3. 519 
 520 
Thus, as it can be observed in Figure 9, BB3 solid is tightly capped in simulated gastric fluid yet 521 
opens and deliver the cargo when in contact with simulated intestinal fluid. Moreover, the most 522 
important thing is that 1 mg of solid BB3 is able to release ca. 95 g of FA during the whole 523 
simulated digestion process. This implicates that the higher recommended dietary intakes in 524 
human nutrition, established for pregnant woman in 600 g per day of folates or 360 g of 525 
synthetic PGA (1 g of dietary folate equivalent = 0.6 g of folic acid) [9, 41], could be reached by 526 
an oral administration of only ca. 4 mg of BB3, which is a remarkable low amount. Moreover, 527 
based in the oral toxicological evaluation of other mesoporous silica particles carried out by 528 
Kupferschmidt et al. [42] -that found that even high amounts of MSP up to 1200 mg of MSP/kg of 529 
rat administrated orally were not toxic - our less than 7 mg are very far of a toxicological effect, 530 
signifying that the optimized solid BB3 could be safe for oral administration.  531 
 532 
 533 
4. Conclusions 534 
 535 
Mesoporous silica particles (MSP) have been recently proposed as smart delivery devices able to 536 
load large amounts of cargo and release the same using different triggering stimuli. In this study 537 
FA has been successfully encapsulated in mesoporous silica particles capped with 3-[2-(2-538 
aminoethylamino)ethylamino]propyl groups. A detailed study of the loading process allowed us to 539 
obtain solids with relative encapsulation efficiencies of the 75%. The simulation of an in vitro 540 
digestion of selected optimized gated support allowed to conclude that the developed MSP 541 
capped with amines were not only able to hinder the release of the vitamin in the presence of a 542 
simulated gastric fluid, but also were able to deliver progressively the vitamin along the time in 543 





























the FA vitamin during the pass across the intestine. In this study it was found that 1 mg of the 545 
optimized solid was able to release ca. 95 g of FA indicating that maximum levels of higher 546 
recommended dietary intakes in human nutrition could be reached using only 4 mg of the 547 
optimized solid. Bearing additionally into account that mesoporous silica particles are non-toxic at 548 
low levels for humans, it can be stated that pH-dependent capped SMP are suitable candidates for 549 
the design of orally applicable delivery systems designed to protect FA from the acidic conditions 550 
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